Researchers Linked Sex to Syndrome Biology

New findings show biological sex influences the molecular pathways involved in Helsmoortel-Van der Aa syndrome.

Updated on Sept. 25, 2026 in Autism

Close-up of a clear glass laboratory flask on a stainless steel surface, illuminated by sterile, cool-toned clinical lighting.
Researchers have discovered that biological sex significantly modifies molecular pathways in Helsmoortel-Van der Aa syndrome, suggesting that future treatments may require sex-specific strategies. AI Illustration. Upload story photo >

Live Poll

Should medical research routinely account for biological sex when studying diseases and drug responses?

Researchers discovered that biological sex acts as a modifier for the molecular biology of Helsmoortel-Van der Aa syndrome. This study utilized both mouse models and data from 129 humans to evaluate the condition.

Why it matters

Understanding how sex influences disease pathways helps researchers determine if potential treatments require tailored approaches. It highlights the importance of analyzing sex-dependent responses to identify the most effective therapeutic strategies.

Researchers studied Adnp heterozygous mice using 24-hour behavioral phenotyping and hippocampal RNA sequencing, comparing findings with clinical data from 129 individuals. Results show Adnp deficiency disrupts molecular patterns in a sex-dependent manner.

The details

Adnp deficiency disrupts brain function in mice through distinct patterns that vary based on biological sex. While the drug candidate davunetide successfully shifted behavioral abnormalities toward healthy states in both sexes, the underlying transcriptional effects were broader in male mice. The study suggests that while outcomes may appear similar, the biological pathways driving them can differ significantly.

Timeline

  1. September 25, 2026: The study was published on biorxiv.org.

Health Landscape

This study advances the current understanding of Helsmoortel-Van der Aa syndrome research by identifying a previously unrecognized molecular modifier. It highlights a shift in neurodevelopmental science toward examining how sex-specific biological responses influence treatment outcomes.

These findings are currently limited to preclinical and observational research and do not change current treatment standards. If you are managing this syndrome, discuss any questions about ongoing research or developmental milestones with your specialist.

The takeaway

Biological sex can play a surprising role in how genetic conditions manifest at the molecular level, even when symptoms appear similar. Future clinical discussions should prioritize monitoring developmental progress and emerging research on personalized treatment pathways.

Further reading

Learn more about the latest research in the Autism section.

More information

Read the full study on sex-dependent syndrome pathology for technical details.

Source note: This article includes information reported by Biorxiv.

Live Poll

Should medical research routinely account for biological sex when studying diseases and drug responses?